NRx Pharmaceuticals(NASDAQ:NRXP) recently reported positive results for experimental drug Zyesami in preventing cytokine storms in patients with COVID-19. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst…
